Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Benigni

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Minerva Stomatologica|May 1, 1987
[Clinical and microbiological effects of a single ultrasonic scaling session in periodontal pockets of different depths]A Benigni, M Paolantonio, M L Curcio, et al.
Journal of Chromatography|October 27, 1989
Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometryC Chiabrando, V Pinciroli, A Campoleoni, et al.
Diabetes|March 31, 1998
Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetesA Benigni, V Colosio, C Brena, et al.
British Journal of Obstetrics and Gynaecology|October 1, 1992
Evidence against a pathogenetic role for endothelin in pre-eclampsiaA Benigni, S Orisio, F Gaspari, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1986
Cyclosporin-induced endothelial cell injuryC Zoja, L Furci, F Ghilardi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1989
Glomerular hyperfiltration and urinary prostaglandins in type 1 diabetes mellitusG C Viberti, A Benigni, E Bognetti, et al.
Transplantation|July 1, 1991
Increased urinary excretion of endothelin-1 and its precursor, Big-endothelin-1, in rats chronically treated with cyclosporineA Benigni, N Perico, J R Ladny, et al.
Human Gene Therapy|July 1, 1997
Nonviral gene delivery to the rat kidney with polyethylenimineA Boletta, A Benigni, J Lutz, et al.
Cancer Treatment Reports|August 1, 1980
Possible relevance of N-trifluoroacetyladriamycin (AD 41) in the antitumoral activity of N-trifluoroacetyladriamycin-14-valerate (AD 32) in tumor-bearing mice. I. Pharmacokinetic evidenceR Abbruzzi, M Rizzardini, A Benigni, et al.
The Journal of Experimental Medicine|November 1, 1994
Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptidesG Remuzzi, M Noris, A Benigni, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Minerva Stomatologica|May 1, 1987
[Clinical and microbiological effects of a single ultrasonic scaling session in periodontal pockets of different depths]A Benigni, M Paolantonio, M L Curcio, et al.
Journal of Chromatography|October 27, 1989
Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometryC Chiabrando, V Pinciroli, A Campoleoni, et al.
Diabetes|March 31, 1998
Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetesA Benigni, V Colosio, C Brena, et al.
British Journal of Obstetrics and Gynaecology|October 1, 1992
Evidence against a pathogenetic role for endothelin in pre-eclampsiaA Benigni, S Orisio, F Gaspari, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1986
Cyclosporin-induced endothelial cell injuryC Zoja, L Furci, F Ghilardi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1989
Glomerular hyperfiltration and urinary prostaglandins in type 1 diabetes mellitusG C Viberti, A Benigni, E Bognetti, et al.
Transplantation|July 1, 1991
Increased urinary excretion of endothelin-1 and its precursor, Big-endothelin-1, in rats chronically treated with cyclosporineA Benigni, N Perico, J R Ladny, et al.
Human Gene Therapy|July 1, 1997
Nonviral gene delivery to the rat kidney with polyethylenimineA Boletta, A Benigni, J Lutz, et al.
Cancer Treatment Reports|August 1, 1980
Possible relevance of N-trifluoroacetyladriamycin (AD 41) in the antitumoral activity of N-trifluoroacetyladriamycin-14-valerate (AD 32) in tumor-bearing mice. I. Pharmacokinetic evidenceR Abbruzzi, M Rizzardini, A Benigni, et al.
The Journal of Experimental Medicine|November 1, 1994
Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptidesG Remuzzi, M Noris, A Benigni, et al.
Pageof 15